Research Clinical Trials Obesity
A new device for weight loss — a swallowable gastric balloon that requires no invasive procedures — may soon be approved by the U.S. Food and Drug Administration (FDA) after a nationwide clinical trial that is being overseen by Shelby Sullivan, MD, professor of gastroenterology at the University of Colorado School of Medicine and director of the Metabolic and Bariatric Program.
Research Community Public Health Obesity
The diet a mother consumes while pregnant may increase the risk for non-alcoholic fatty liver disease (NAFLD) in the offspring, new research shows.
Following up on a 2018 study that identified an epigenetic modifier known as histone deacetylase 11 (HDAC11) as a potential therapeutic target for treating obesity and diabetes, researchers from the University of Colorado School of Medicine have published new research that finds HDAC11 regulates G protein-coupled receptors (GPCRs) called beta-adrenergic receptors (β-ARs).
CPR
July 25, 2024
In Colorado and across the nation, emergency departments at pediatric hospitals are overflowing with kids who need intensive mental health treatment.
9News
July 23, 2024
A little more than a month after the Olympics wrap up, women triathletes will be heading to the south of France for another competition on the global stage.
Healthy Debate
July 18, 2024
In 1961, Yuri Gagarin became the first human in space. With every kilometre he ascended, he pushed the boundaries of human achievement and catalyzed a surge of interest in exploration, research, development – and medical innovation.
Medscape
July 18, 2024
Experts debating the pressing issue of how to prioritize patients in the increasingly common scenario of loss of access or insurance coverage for anti-obesity glucagon-like peptide 1 (GLP-1) receptor agonist drugs argued that comorbidities and obesity severity should strongly warrant continued coverage — while offering key strategies for getting and retaining approval from payers.
Greg Glasgow
